Pharma · Private company
Janssen Sciences Ireland UC
Track this companyFree. Adds Janssen Sciences Ireland UC to your Dealase workspace and tells you when its record changes.
Clinical trials70 recruiting or active
Pipeline programs18From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline18
- Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide FDCPhase 3 · Immunodeficiency Virus Type 1, HumanClinicalTrials.gov · fetched Nov 12, 2026
- DRV/COBI FDCPhase 3 · Immunodeficiency Virus Type 1, HumanClinicalTrials.gov · fetched Nov 12, 2026
- EtravirinePhase 3 · HIV InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- FTC/TDF FDCPhase 3 · Immunodeficiency Virus Type 1, HumanClinicalTrials.gov · fetched Nov 12, 2026
- AbacavirPhase 2 · HIV-1ClinicalTrials.gov · fetched Nov 12, 2026
- EmtricitabinePhase 2 · HIV-1ClinicalTrials.gov · fetched Nov 12, 2026
- JNJ-53718678 125 mgPhase 2 · Respiratory Syncytial Virus InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- JNJ-53718678 250 mgPhase 2 · Respiratory Syncytial Virus InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- JNJ-56136379Phase 2 · Hepatitis B, ChronicClinicalTrials.gov · fetched Nov 12, 2026
- JNJ-56136379Phase 2 · Hepatitis BClinicalTrials.gov · fetched Nov 12, 2026
- JNJ-73763989Phase 2 · Hepatitis B, ChronicClinicalTrials.gov · fetched Nov 12, 2026
- LamivudinePhase 2 · HIV-1ClinicalTrials.gov · fetched Nov 12, 2026
- NA (ETV or TDF)Phase 2 · Hepatitis BClinicalTrials.gov · fetched Nov 12, 2026
- Nucleos(t)ide Analog (NA)Phase 2 · Hepatitis B, ChronicClinicalTrials.gov · fetched Nov 12, 2026
- RilpivirinePhase 2 · HIV-1ClinicalTrials.gov · fetched Nov 12, 2026
- Tenofovir disoproxil fumaratePhase 2 · HIV-1ClinicalTrials.gov · fetched Nov 12, 2026
- ZidovudinePhase 2 · HIV-1ClinicalTrials.gov · fetched Nov 12, 2026
- JNJ-53718678Phase 1 · Respiratory Syncytial Virus InfectionsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials7
- Effects of JNJ-53718678 in Adult and Adolescent Participants Who Had a Hematopoietic Stem Cell Transplantation and Who Are Infected With Respiratory Syncytial Virus (RSV)PHASE2 · TERMINATED · started Dec 26, 2019ClinicalTrials.gov NCT04056611 · fetched Nov 12, 2026
- A Study of Different Combination Regimens Including JNJ-73763989 and/or JNJ-56136379 for the Treatment of Chronic Hepatitis B Virus InfectionPHASE2 · COMPLETED · started Aug 1, 2019ClinicalTrials.gov NCT03982186 · fetched Nov 12, 2026
- An Efficacy, Safety, and Pharmacokinetics Study of JNJ-56136379 in Participants With Chronic Hepatitis B Virus InfectionPHASE2 · COMPLETED · started Feb 13, 2018ClinicalTrials.gov NCT03361956 · fetched Nov 12, 2026
- A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Multiple Doses of Orally Administered JNJ-53718678 in Infants Hospitalized With Respiratory Syncytial Virus (RSV) InfectionPHASE1 · TERMINATED · started Dec 4, 2015ClinicalTrials.gov NCT02593851 · fetched Nov 12, 2026
- A Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Fixed Dose Combination (FDC) Versus a Regimen Consisting of Darunavir/Cobicistat FDC With Emtricitabine/Tenofovir Disoproxil Fumarate FDC in Treatment-naive HIV Type 1 Infected SubjectsPHASE3 · COMPLETED · started Jul 6, 2015ClinicalTrials.gov NCT02431247 · fetched Nov 12, 2026
- A Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Activity of Rilpivirine (TMC278) in Human Immunodeficiency Virus Infected Adolescents and Children Aged Greater Than or Equal to 6 YearsPHASE2 · COMPLETED · started Jan 1, 2011ClinicalTrials.gov NCT00799864 · fetched Nov 12, 2026
- TMC125-TiDP35-C239 - Continued Access to Etravirine (ETR) in Treatment Experienced HIV-1 Infected ParticipantsPHASE3 · COMPLETED · started Dec 9, 2009ClinicalTrials.gov NCT00980538 · fetched Nov 12, 2026